The inspection has concluded successfully on 1st September 2023 without any critical/major observation
Brian Foard will lead the Specialty Care GBU ad interim, effective immediately.
Reblozyl is the first and only therapy to demonstrate superiority compared to an erythropoiesis stimulating agent (ESA) in MDS-related anemia
The updated COVID-19 vaccine is tailored to the Omicron XBB.1.5 sublineage of SARS-CoV-2 and is recommended for individuals 6 months of age and older
The approval bolsters the company's Mycophenolate Mofetil portfolio
Topiramate is the generic version of Supernus Pharmaceuticals’ Trokendi XR
Mankind Pharma's initiative aims to ensure universal access to medicines of international calibre
KEYTRUDA is the first immunotherapy approved in the EU for the first-line treatment of this patient population
Hospital joins with Intuitive to install da Vinci systems to support enhanced healthcare delivery and patient outcomes across India
Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year
Subscribe To Our Newsletter & Stay Updated
